Eli Lilly and Company (LLY) at a glance
Eli Lilly and Company (LLY) is a mega-cap Healthcare company. It trades at $1116.2, with a P/E of 41.3, a 35% profit margin and revenue growth of 55.5%. It pays a 0.6% dividend yield. Vestovix scores it 66/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Income (35/100). It is a relatively defensive holding with below-market volatility.
- Price
- $1,116.20
- Market cap
- $1.01T
- P/E ratio
- 41.3
- Dividend yield
- 0.57%
- Beta
- 0.52
- 52-week range
- $712.05 to $1,292.65
Value
50
Growth
94
Income
35
Safety
84
Momentum
64
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
JNJ61
Johnson & Johnson
$266.20+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$257.12-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$378.73-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$144.01-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.57+0.92%
2.16% yield
AMGN65
Amgen Inc.
$378.21-1.05%
2.76% yield
TMO54
Thermo Fisher Scientific Inc.
$609.82-1.39%
0.38% yield